Mini-dose of thalidomide for treatment of primary myelofibrosis. Report of a case with complete reversal of bone marrow fibrosis and splenomegaly.

Haematologica

Volumn 92, Issue 2, 2007, Pages

  Berrebi, Alain ^a   Feldberg, Edit ^a   Spivak, Irena ^a   Shvidel, Lev ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; FLUOXYMESTERONE; FOLIC ACID; PREDNISONE; THALIDOMIDE; VITAMIN B COMPLEX;

AGED; ARTICLE; BLOOD TRANSFUSION; BONE MARROW; CASE REPORT; DRUG COMBINATION; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; MYELOFIBROSIS; PATHOLOGY; REMISSION; SPLENOMEGALY;

AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; BLOOD TRANSFUSION; BONE MARROW; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; FLUOXYMESTERONE; FOLIC ACID; HUMANS; MALE; MYELOFIBROSIS; PREDNISONE; REMISSION INDUCTION; SPLENOMEGALY; THALIDOMIDE; VITAMIN B COMPLEX;

EID: 38449097977     PISSN: None     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.10684     Document Type: Article

References (0)